LY-364947

CAS No. 396129-53-6

LY-364947( HTS 466284 | TGF-β RI Kinase Inhibitor )

Catalog No. M14364 CAS No. 396129-53-6

LY364947 is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM in a cell-free assay, shows 7-fold selectivity over TGFβR-II.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 63 In Stock
5MG 56 In Stock
10MG 71 In Stock
25MG 139 In Stock
50MG 249 In Stock
100MG 365 In Stock
200MG 548 In Stock
500MG 858 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LY-364947
  • Note
    Research use only, not for human use.
  • Brief Description
    LY364947 is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM in a cell-free assay, shows 7-fold selectivity over TGFβR-II.
  • Description
    LY364947 is a potent ATP-competitive inhibitor of TGFβR-I with IC50 of 59 nM in a cell-free assay, shows 7-fold selectivity over TGFβR-II.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    HTS 466284 | TGF-β RI Kinase Inhibitor
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    CK1δ| MLK-7K| TGFβRI| TGFβRII| RIPK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    396129-53-6
  • Formula Weight
    272.3
  • Molecular Formula
    C17H12N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 1 mg/mL (3.67 mM)
  • SMILES
    C1(C2=CNN=C2C3=NC=CC=C3)=CC=NC4=CC=CC=C14
  • Chemical Name
    4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)quinoline

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li HY, et al. J Med Chem, 2006, 49(6), 2138-2142.
molnova catalog
related products
  • Epiblastin A

    Epiblastin A is an inhibitor of Casein Kinase 1 (CK1).?Epiblastin A engages CK1 isoenzymes in cell lysate and induces efficient conversion of epiblast stem cells (EpiSCs) into embryonic stem cells (cESCs).

  • NCC007

    NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin.

  • CX-4945 sodium salt

    A potent, selective, orally bioavailable, ATP-competitive inhibitor of protein kinase CK2 with Ki of 0.38 nM, CK2α IC50 of 1 nM.